Cargando…

Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness

BACKGROUND: Endothelial activation plays a role in organ dysfunction in the systemic inflammatory response syndrome (SIRS). Angiopoietin-1 (Ang-1) promotes vascular quiescence while angiopoietin-2 (Ang-2) mediates microvascular leak. Circulating levels of Ang-1 and Ang-2 in patients with SIRS could...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikacenic, Carmen, Hahn, William O., Price, Brenda L., Harju-Baker, Susanna, Katz, Ronit, Kain, Kevin C., Himmelfarb, Jonathan, Liles, W. Conrad, Wurfel, Mark M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619633/
https://www.ncbi.nlm.nih.gov/pubmed/26492036
http://dx.doi.org/10.1371/journal.pone.0141251
_version_ 1782397147363147776
author Mikacenic, Carmen
Hahn, William O.
Price, Brenda L.
Harju-Baker, Susanna
Katz, Ronit
Kain, Kevin C.
Himmelfarb, Jonathan
Liles, W. Conrad
Wurfel, Mark M.
author_facet Mikacenic, Carmen
Hahn, William O.
Price, Brenda L.
Harju-Baker, Susanna
Katz, Ronit
Kain, Kevin C.
Himmelfarb, Jonathan
Liles, W. Conrad
Wurfel, Mark M.
author_sort Mikacenic, Carmen
collection PubMed
description BACKGROUND: Endothelial activation plays a role in organ dysfunction in the systemic inflammatory response syndrome (SIRS). Angiopoietin-1 (Ang-1) promotes vascular quiescence while angiopoietin-2 (Ang-2) mediates microvascular leak. Circulating levels of Ang-1 and Ang-2 in patients with SIRS could provide insight on risks for organ dysfunction and death distinct from inflammatory proteins. In this study, we determined if biomarkers of endothelial activation and inflammation exhibit independent associations with poor outcomes in SIRS. METHODS: We studied 943 critically ill patients with SIRS admitted to an Intensive Care Unit (ICU) of an academic medical center. We measured plasma levels of endothelial markers (Ang-1, Ang-2, soluble vascular cell adhesion molecule-1 (sVCAM-1)) and inflammatory markers (interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte-colony stimulating factor (G-CSF), soluble tumor necrosis factor receptor-1 (sTNFR-1)) within 24 hours of enrollment. We tested for associations between each marker and 28 day mortality, shock, and day 3 sequential organ failure assessment (SOFA) score. For 28 day mortality, we performed sensitivity analysis for those subjects with sepsis and those with sterile inflammation. We used multivariate models to adjust for clinical covariates and determine if associations identified with endothelial activation markers were independent of those observed with inflammatory markers. RESULTS: Higher levels of all biomarkers were associated with increased 28 day mortality except levels of Ang-1 which were associated with lower mortality. After adjustment for comorbidities and sTNFR-1 concentration, a doubling of Ang-1 concentration was associated with lower 28 day mortality (Odds ratio (OR) = 0.81; p<0.01), shock (OR = 0.82; p<0.001), and SOFA score (β = -0.50; p<0.001), while Ang-2 concentration was associated with increased mortality (OR = 1.55; p<0.001), shock (OR = 1.51; p<0.001), and SOFA score (β = +0.63; p<0.001). sVCAM-1 was not independently associated with SIRS outcomes. CONCLUSIONS: In critically ill patients with SIRS, early measurements of Ang-1 and Ang-2 are associated with death and organ dysfunction independently of simultaneously-measured markers of inflammation.
format Online
Article
Text
id pubmed-4619633
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46196332015-10-29 Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness Mikacenic, Carmen Hahn, William O. Price, Brenda L. Harju-Baker, Susanna Katz, Ronit Kain, Kevin C. Himmelfarb, Jonathan Liles, W. Conrad Wurfel, Mark M. PLoS One Research Article BACKGROUND: Endothelial activation plays a role in organ dysfunction in the systemic inflammatory response syndrome (SIRS). Angiopoietin-1 (Ang-1) promotes vascular quiescence while angiopoietin-2 (Ang-2) mediates microvascular leak. Circulating levels of Ang-1 and Ang-2 in patients with SIRS could provide insight on risks for organ dysfunction and death distinct from inflammatory proteins. In this study, we determined if biomarkers of endothelial activation and inflammation exhibit independent associations with poor outcomes in SIRS. METHODS: We studied 943 critically ill patients with SIRS admitted to an Intensive Care Unit (ICU) of an academic medical center. We measured plasma levels of endothelial markers (Ang-1, Ang-2, soluble vascular cell adhesion molecule-1 (sVCAM-1)) and inflammatory markers (interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte-colony stimulating factor (G-CSF), soluble tumor necrosis factor receptor-1 (sTNFR-1)) within 24 hours of enrollment. We tested for associations between each marker and 28 day mortality, shock, and day 3 sequential organ failure assessment (SOFA) score. For 28 day mortality, we performed sensitivity analysis for those subjects with sepsis and those with sterile inflammation. We used multivariate models to adjust for clinical covariates and determine if associations identified with endothelial activation markers were independent of those observed with inflammatory markers. RESULTS: Higher levels of all biomarkers were associated with increased 28 day mortality except levels of Ang-1 which were associated with lower mortality. After adjustment for comorbidities and sTNFR-1 concentration, a doubling of Ang-1 concentration was associated with lower 28 day mortality (Odds ratio (OR) = 0.81; p<0.01), shock (OR = 0.82; p<0.001), and SOFA score (β = -0.50; p<0.001), while Ang-2 concentration was associated with increased mortality (OR = 1.55; p<0.001), shock (OR = 1.51; p<0.001), and SOFA score (β = +0.63; p<0.001). sVCAM-1 was not independently associated with SIRS outcomes. CONCLUSIONS: In critically ill patients with SIRS, early measurements of Ang-1 and Ang-2 are associated with death and organ dysfunction independently of simultaneously-measured markers of inflammation. Public Library of Science 2015-10-22 /pmc/articles/PMC4619633/ /pubmed/26492036 http://dx.doi.org/10.1371/journal.pone.0141251 Text en © 2015 Mikacenic et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Mikacenic, Carmen
Hahn, William O.
Price, Brenda L.
Harju-Baker, Susanna
Katz, Ronit
Kain, Kevin C.
Himmelfarb, Jonathan
Liles, W. Conrad
Wurfel, Mark M.
Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness
title Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness
title_full Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness
title_fullStr Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness
title_full_unstemmed Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness
title_short Biomarkers of Endothelial Activation Are Associated with Poor Outcome in Critical Illness
title_sort biomarkers of endothelial activation are associated with poor outcome in critical illness
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619633/
https://www.ncbi.nlm.nih.gov/pubmed/26492036
http://dx.doi.org/10.1371/journal.pone.0141251
work_keys_str_mv AT mikaceniccarmen biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness
AT hahnwilliamo biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness
AT pricebrendal biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness
AT harjubakersusanna biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness
AT katzronit biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness
AT kainkevinc biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness
AT himmelfarbjonathan biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness
AT lileswconrad biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness
AT wurfelmarkm biomarkersofendothelialactivationareassociatedwithpooroutcomeincriticalillness